Skip to main content

Table 3 Breakdown of reduction in drug cost by individual preparation and by DVO preparation for the top 10 items by difference in amount (US $)

From: Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital

Ranking of cost savings

1st

2nd

3rd

4th

5th

6th

7th

8th

9th

10th

Drug name

Bevacizumab

nab-Paclitaxel

Nivolumab

Ramucirumab

Trastuzumab

Panitumumab

Oxaliplatin

Cetuximab

Irinotecan

Paclitaxel

Drug cost by individual preparation

436,858

256,228

1,036,991

253,065

172,841

185,129

99,009

97,670

22,896

42,448

Drug cost by DVO preparation

389,034

208,465

1,012,020

232,808

158,831

171,704

87,125

91,964

17,662

37,752

Cost saved

47,824

47,763

24,971

20,257

14,010

13,425

11,884

5706

5234

4696

  1. US$1 = ¥110
  2. DVO Drug vial optimization